The facility will produce a range of messenger RNA vaccines that can fight respiratory viruses such as seasonal flu.
American vaccine maker Moderna chose Montreal to build its highly anticipated Canadian manufacturing facility.
Moderna plans to produce not only vaccines against COVID-19 in Quebec, but also a range of messenger RNA vaccines that can fight respiratory viruses such as seasonal influenza and respiratory syncytial virus. The vaccines must be approved by regulatory authorities.
Moderna’s decision was officially announced Friday at McGill University during a press conference hosted by Canadian Prime Minister Justin Trudeau and Quebec Prime Minister François Legault.
McGill CEO Suzanne Fortier said in the opening remarks that she looks forward to partnership opportunities with Moderna.
The plant is a $180 million project, Legault said. Trudeau added that the factory will create hundreds of high-paying jobs.